WallStSmart

Align Technology Inc (ALGN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Align Technology Inc stock (ALGN) is currently trading at $180.27. Align Technology Inc PE ratio is 31.74. Align Technology Inc PS ratio (Price-to-Sales) is 3.19. Analyst consensus price target for ALGN is $201.69. WallStSmart rates ALGN as Moderate Buy.

  • ALGN PE ratio analysis and historical PE chart
  • ALGN PS ratio (Price-to-Sales) history and trend
  • ALGN intrinsic value — DCF, Graham Number, EPV models
  • ALGN stock price prediction 2025 2026 2027 2028 2029 2030
  • ALGN fair value vs current price
  • ALGN insider transactions and insider buying
  • Is ALGN undervalued or overvalued?
  • Align Technology Inc financial analysis — revenue, earnings, cash flow
  • ALGN Piotroski F-Score and Altman Z-Score
  • ALGN analyst price target and Smart Rating
ALGN

Align Technology Inc

NASDAQHEALTHCARE
$180.27
$0.93 (0.52%)
52W$122.00
$208.31
Target$201.69+11.9%

📊 No data available

Try selecting a different time range

IV

ALGN Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Align Technology Inc (ALGN)

Margin of Safety
+25.3%
Undervalued
ALGN Fair Value
$264.42
Graham Formula
Current Price
$180.27
$84.15 below fair value
Undervalued
Fair: $264.42
Overvalued
Price $180.27
Graham IV $264.42
Analyst $201.69

ALGN appears undervalued based on the Graham Formula, trading 25% below its estimated fair value of $264.42.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Align Technology Inc (ALGN) · 10 metrics scored

Smart Score

68
out of 100
Grade: B-
Strong Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, peg ratio, operating margin. Overall metrics suggest strong investment potential with favorable risk/reward.

Align Technology Inc (ALGN) Key Strengths (5)

Avg Score: 9.0/10
EPS GrowthGrowth
35.60%10/10

Earnings per share surging 35.60% year-over-year

Institutional Own.Quality
96.16%10/10

96.16% of shares held by major funds and institutions

Market CapQuality
$12.87B9/10

Large-cap company with substantial market presence

PEG RatioValuation
1.068/10

Good growth relative to its price

Operating MarginProfitability
22.40%8/10

Strong operational efficiency: $22 kept per $100 revenue

Supporting Valuation Data

EV/Revenue
2.952
Undervalued

Align Technology Inc (ALGN) Areas to Watch (5)

Avg Score: 5.0/10
Price/BookValuation
3.184/10

Premium pricing at 3.2x book value

Revenue GrowthGrowth
5.30%4/10

Modest revenue growth at 5.30%

Return on EquityProfitability
10.40%5/10

Moderate profitability with room for improvement

Price/SalesValuation
3.196/10

Revenue is fairly priced at 3.19x sales

Profit MarginProfitability
10.20%6/10

Decent profitability, keeps $10 per $100 revenue

Supporting Valuation Data

P/E Ratio
31.74
Expensive
Trailing P/E
31.74
Expensive

Align Technology Inc (ALGN) Detailed Analysis Report

Overall Assessment

This company scores 68/100 in our Smart Analysis, earning a B- grade. Out of 10 metrics analyzed, 5 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 5.0/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.

The Bull Case

The strongest argument centers on EPS Growth, Institutional Own., Market Cap. Valuation metrics including PEG Ratio (1.06) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 22.40%. Growth metrics are encouraging with EPS Growth at 35.60%.

The Bear Case

The primary concerns are Price/Book, Revenue Growth, Return on Equity. Some valuation metrics including Price/Sales (3.19), Price/Book (3.18) suggest expensive pricing. Growth concerns include Revenue Growth at 5.30%, which may limit upside. Profitability pressure is visible in Return on Equity at 10.40%, Profit Margin at 10.20%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Price/Book improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 10.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 5.30% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (EPS Growth, Institutional Own.) and negatives (Price/Book, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

ALGN Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

ALGN's Price-to-Sales ratio of 3.19x trades 49% below its historical average of 6.26x (16th percentile). The current valuation is 83% below its historical high of 18.38x set in Sep 2018, and 113% above its historical low of 1.5x in Feb 2009.

Compare ALGN with Competitors

Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Align Technology Inc (ALGN) · HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

The Big Picture

Align Technology Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 4.0B with 5% growth year-over-year. Profit margins of 10.2% are healthy, with room for further expansion as the business scales.

Key Findings

Cash Flow Positive

Generating 157M in free cash flow and 223M in operating cash flow. Earnings are translating into actual cash generation.

What to Watch Next

Margin expansion: can Align Technology Inc push profit margins above 15% as the business scales?

Volatility is elevated with a beta of 1.82, so expect amplified moves relative to the broader market.

Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Align Technology Inc.

Bottom Line

Align Technology Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Align Technology Inc(ALGN)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL INSTRUMENTS & SUPPLIES

Country

USA

Align Technology is a manufacturer of 3D digital scanners and the Invisalign clear aligners used in orthodontics. It is headquartered in San Jose, California.